Rejuvenation Research

From Wikipedia, the free encyclopedia

You have new messages (last change).
Aubrey de Grey is Editor-in-Chief of the Rejuvenation Research journal, which deals with topics related to engineered negligible senescence. The journal's editorial board includes figures from the relevant areas of biology and its social context, including stem cell therapy, tissue engineering, gene therapy, public policy, cancer therapies, and demography.
Aubrey de Grey is Editor-in-Chief of the Rejuvenation Research journal, which deals with topics related to engineered negligible senescence. The journal's editorial board includes figures from the relevant areas of biology and its social context, including stem cell therapy, tissue engineering, gene therapy, public policy, cancer therapies, and demography.

Rejuvenation Research is a multidisciplinary peer-reviewed quarterly scientific journal published by Mary Ann Liebert, Inc. that investigates the mechanisms of aging. The 2005 impact factor for Rejuvenation Research is 8.571[1], midway between the impact factor of Archives of Internal Medicine and the British Medical Journal[2]

Edited by Aubrey de Grey, the journal addresses such issues as cardiovascular aging, cell immortalization and senescence, cloning/ESCs, DNA damage/repair, growth factors, immunology, invertebrate lifespan, neurodegeneration, tissue engineering, public policy, gene targeting, gene therapy, and genomics.

[edit] See also

[edit] References

  1. ^ de Grey, Aubrey. SENS (Strategies for Engineered Negligible Senescence). Retrieved on September 11, 2006.
  2. ^ ISI Impact Factors for leading medical and science journals in 2005, in Epidemiologic Inquiry.

[edit] External links

Retrieved from "http://en.wikipedia.org../../../r/e/j/Rejuvenation_Research_ce95.html"